Genetic Signatures Limited (ASX:GSS)
Australia
· Delayed Price · Currency is AUD 0.0950
-0.0050 (-5.00%)
At close: Mar 6, 2026
Genetic Signatures Company Description
Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
It offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, extended respiratory, atypical respiratory, Measles, Mumps, and Rubella detection kits under the EasyScreen name.
The company was incorporated in 2001 and is headquartered in Newtown, Australia.
Genetic Signatures Limited
| Country | Australia |
| Founded | 2001 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | Maria Halasz |
Contact Details
Address: Heart Research Institute Newtown, NSW 2042 Australia | |
| Phone | 61 2 9870 7580 |
| Website | geneticsignatures.com |
Stock Details
| Ticker Symbol | GSS |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000GSS4 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Allison Rossiter | Chief Executive Officer |
| Michael Anton Aicher BSc, M.B.A. | Executive Director of US Operations and Executive Director |
| Anne Nicole Lockwood B.Com., C.A., F.C.A. | Interim MD and Director |
| Christopher M. Abbott A.M., F.C.A., Ph.D., Ph.D., (Hon) | Founder and Chairman Emeritus |
| Dr. Susanne K. Pedersen Ph.D. | Chief Technology Officer |
| Rebecca Abbatantuono | Global Head of People and Culture |